Evidence map›Paper›PMID 36009236›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Potential Molecular Targets of Oleanolic Acid in Insulin Resistance and Underlying Oxidative Stress: A Systematic Review.

Ángel Fernández-Aparicio, María Correa-Rodríguez, Jose M Castellano, Jacqueline Schmidt-RioValle, Javier S Perona, Emilio González-Jiménez

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05529953 (Bioavailability Assays of Oleanolic Acid, Formulated as Functional Olive Oil, in Healthy Subjects. Pharmacokinetic Analysis and Study of Its Integration in Postprandial Human Triglyceride-Rich Lipoproteins), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05529953 nacompletednot on this map

Bioavailability Assays of Oleanolic Acid, Formulated as Functional Olive Oil, in Healthy Subjects. Pharmacokinetic Analysis and Study of Its Integration in Postprandial Human Triglyceride-Rich Lipoproteins

TypeinterventionalSponsorSpanish National Research CouncilRan2021 to 2021Enrolled22ConditionsHealthy Subjects, BioavailabilityArmsOleanolic acid (CAS no. 598-02-1, PubChem CID 10494), Control commercial olive oil
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Foods (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ángel Fernández-AparicioDepartment of Nursing, Faculty of Health Sciences, Melilla Campus, University of Granada, 52005 Melilla, Spain.ORCID 0000-0002-1298-8349
María Correa-RodríguezInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, Spain.ORCID 0000-0001-9165-4349
Jose M CastellanoDepartment of Food and Health, Instituto de la Grasa-CSIC, Campus of the University Pablo de Olavide, 41013 Seville, Spain.ORCID 0000-0003-3051-3264
Jacqueline Schmidt-RioValleDepartment of Nursing, Faculty of Health Sciences, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-2775-0058
Javier S PeronaDepartment of Food and Health, Instituto de la Grasa-CSIC, Campus of the University Pablo de Olavide, 41013 Seville, Spain.ORCID 0000-0001-5919-993X
Emilio González-JiménezInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, Spain.ORCID 0000-0001-5103-6028
Universidad de Granada · ESInstituto de la Grasa · ES

Funding

Andalusia 2014-2020 European Regional Development Fund (ERDF) Operative Program B-AGR-287-UGR18
6 · The paper itself

Abstract

Oleanolic acid (OA) is a natural triterpene widely found in olive leaves that possesses antioxidant, anti-inflammatory, and insulin-sensitizing properties, among others. These OA characteristics could be of special interest in the treatment and prevention of insulin resistance (IR), but greater in-depth knowledge on the pathways involved in these properties is still needed. We aimed to systematically review the effects of OA on the molecular mechanisms and signaling pathways involved in the development of IR and underlying oxidative stress in insulin-resistant animal models or cell lines. The bibliographic search was carried out on PubMed, Web of Science, Scopus, Cochrane, and CINHAL databases between January 2001 and May 2022. The electronic search produced 5034 articles but, after applying the inclusion criteria, 13 animal studies and 3 cell experiments were identified, using SYRCLE's Risk of Bias for assessing the risk of bias of the animal studies. OA was found to enhance insulin sensitivity and glucose uptake, and was found to suppress the hepatic glucose production, probably by modulating the IRS/PI3K/Akt/FoxO1 signaling pathway and by mitigating oxidative stress through regulating MAPK pathways. Future randomized controlled clinical trials to assess the potential benefit of OA as new therapeutic and preventive strategies for IR are warranted.

Indexed as

bioactive compoundsinflammationinsulin resistanceinsulin signalingOlea europaeaoleanolic acidoxidative stresspathwaystriterpenestype 2 diabetes mellitus

Identifiers

PMID36009236
PMCPMC9404892
OpenAlexW4289704816

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.